- Home
- CPIX vs NMS Comparison
CPIX vs NMS Comparison
Compare CPIX & NMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- NMS
- Stock Information
- Founded
- CPIX 1999
- NMS 1993
- Country
- CPIX United States
- NMS United States
- Employees
- CPIX N/A
- NMS N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- NMS Finance Companies
- Sector
- CPIX Health Care
- NMS Finance
- Exchange
- CPIX Nasdaq
- NMS Nasdaq
- Market Cap
- CPIX 68.7M
- NMS 68.7M
- IPO Year
- CPIX 2009
- NMS N/A
- Fundamental
- Price
- CPIX $4.73
- NMS $11.36
- Analyst Decision
- CPIX
- NMS
- Analyst Count
- CPIX 0
- NMS 0
- Target Price
- CPIX N/A
- NMS N/A
- AVG Volume (30 Days)
- CPIX 44.3K
- NMS 12.0K
- Earning Date
- CPIX 08-05-2025
- NMS 01-01-0001
- Dividend Yield
- CPIX N/A
- NMS 4.11%
- EPS Growth
- CPIX N/A
- NMS N/A
- EPS
- CPIX N/A
- NMS N/A
- Revenue
- CPIX $41,083,299.00
- NMS N/A
- Revenue This Year
- CPIX N/A
- NMS N/A
- Revenue Next Year
- CPIX N/A
- NMS N/A
- P/E Ratio
- CPIX N/A
- NMS N/A
- Revenue Growth
- CPIX 5.82
- NMS N/A
- 52 Week Low
- CPIX $1.04
- NMS $9.21
- 52 Week High
- CPIX $7.25
- NMS $12.18
- Technical
- Relative Strength Index (RSI)
- CPIX 50.35
- NMS 45.28
- Support Level
- CPIX $5.11
- NMS $11.31
- Resistance Level
- CPIX $5.88
- NMS $11.49
- Average True Range (ATR)
- CPIX 0.41
- NMS 0.09
- MACD
- CPIX -0.05
- NMS 0.01
- Stochastic Oscillator
- CPIX 37.67
- NMS 50.00
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
About NMS Nuveen Minnesota Quality Municipal Income Fund
Nuveen Minnesota Quality Municipal Income Fund is a diversified closed-end management investment company. The Fund's primary investment objective is current income exempt from both regular federal income taxes and Minnesota state income taxes and its secondary investment objective is the enhancement of portfolio value.